Pharmafile Logo
Pharmafocus logo
Advanced Search

Pfizer revenues down, but above expectations

February 3, 2016
Research and Development, Sales and Marketing Ian Read, Pfizer, financial results, income, profits, revenue, sales

Pfizer’s revenues took a hit from generic competition on former blockbusters, but the world’s new largest drugmaker still managed to …

News
dr_barbara_fleck_-_head_of_ip-web

Crescendo Biologics appoints Dr Barbara Fleck as head of intellectual property

February 2, 2016
Research and Development Crescendo Biologics

Drug discovery and developer Crescendo Biologics has appointed Dr Barbara Fleck as head of intellectual property. Barbara Fleck, a European and …

Appointment

PCI and Partners host San Diego and San Francisco Serialization events

February 2, 2016
Manufacturing and Production

Professionals working in life science packaging and logistics can learn more about the fast-changing topic of Serialization at two free …

News
Press release

Porton Biopharma expands cancer drug manufacturing capacity

February 2, 2016
Manufacturing and Production, Research and Development Erwinase

UK Life Sciences Minister George Freeman yesterday opened a new multi-million pound pharmaceutical manufacturing facility at Wiltshire-based Porton Biopharma Limited …

News
sun_pharma_logo

Sun Pharma takes on Novartis in the US with generic Glivec

February 2, 2016
Manufacturing and Production, Research and Development, Sales and Marketing Gleevec, Novartis, Sun Pharma

Mumbai-based drug manufacturer Sun Pharma has launched a generic version of Glivec, for the same indications for which the former …

News
sanofi

Sanofi Pasteur launches Zika vaccine R&D

February 2, 2016
Manufacturing and Production, Research and Development Sanofi Pasteur, Vaccine, Zika virus

Sanofi Pasteur, the vaccines division of French pharma giant Sanofi, says it has launched a vaccine research and development project …

News
bms_logo_square

Europe approves BMS hep C drug for HIV and liver transplant patients

February 1, 2016
Research and Development, Sales and Marketing Bristol-Myers Squibb, daclatasvir, daklinza

The European Commission has approved the expanded use of Bristol Myers-Squibb’s hepatitis C drug Daklinza (daclatasvir), to include liver transplant …

News
abbvie

AbbVie posts strong Q4 results

February 1, 2016
Sales and Marketing AbbVie, Humira, Viekira Pak

AbbVie managed to meet or beat analysts’ expectations in its Q4 financial results report, with extremely strong Humira sales contributing …

News
corbett_issy

PwC appoints Issy Corbett as healthcare M&A partner

February 1, 2016
Sales and Marketing pwC

PwC has appointed Issy Corbett as a partner to lead its healthcare M&A team.Corbett joins PwC from Rothschild, where he …

Appointment
ceo_olivier_bohuon-web_appts

Contigency plans in place while Smith & Nephew boss has cancer treatment

February 1, 2016
Manufacturing and Production Olivier Bohuon, Smith & Nephew, medical devices

Medical technology firm Smith & Nephew has announced that chief executive Olivier Bohuon has been diagnosed with a ‘highly treatable …

Appointment
merck_innovation_centre

Merck launches health tech start-up program in Africa

February 1, 2016
Manufacturing and Production, Medical Communications, Research and Development

Merck has begun its equity-free accelerator program for digital health start-ups in Nairobi, Kenya- a three-month venture offering $15,000 equity-free …

News
Westminster

Ministers reject bid to revive Off Patent Drugs Bill

February 1, 2016
Research and Development, Sales and Marketing Access to Medical Treatments (Innovation) Bill, Off Patent Drugs Bill, Off-Patent Drugs Bill, george freeman, parliament, repurposing drugs

Ministers have rejected amendments to a proposed Parliamentary Bill that sought to reintroduce elements of the Off Patent Drugs Bill, …

News
EMA inside

Actelion’s Uptravi and rare bleeding disorder drug get positive EMA decisions

February 1, 2016
Sales and Marketing CHMP, EMA, Uptravi, pulmonary arterial hypertension, selexipag

The Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the EMA, has issued positive opinions on …

News
Empliciti pack shot

EMA fast-tracks BMS multiple myeloma drug

February 1, 2016
Sales and Marketing AbbVie, BMS, Bristol-Myers Squibb, EMA, Empliciti, myeloma

The EMA has recommended granting a marketing authorisation for Bristol Myers-Squibb and AbbVie’s immunotherapy Empliciti for the treatment of multiple myeloma. The …

News
john_milligan_gilead_sciences

Gilead Sciences names John Milligan new CEO

January 29, 2016
Medical Communications, Sales and Marketing Gilead Sciences, John Martin, John Milligan

Gilead Sciences has announced that chairman and chief executive John Martin is to step down after 20 years at the …

Appointment
allergan

Allergan’s depression drug awarded FDA Breakthrough Therapy status

January 29, 2016
Research and Development, Sales and Marketing Allergan, depression, rapastinel

While still adjusting to life as part of Pfizer, Allergan has received some good news in the form of the …

News
business_generic

Pharma: How to make mergers work

January 29, 2016
Sales and Marketing mergers and acquisitions

Pharma is no stranger to bursts of M&A activity.

Feature
ABPI code

Regulation of drug promotion ‘should be toughened up’, study finds

January 29, 2016
Medical Communications ABPI Code, Department of Justice, PMCPA, Prescription Medicines Code of Practice Authority, Sunshine Act, marketing, off label, off-label, promotion

The voluntary code of conduct system that regulates the pharma industry’s promotion of off-label prescribing has a ‘limited capacity’ to …

News
Merck image

MSD gets FDA approval for hepatitis C drug Zepatier

January 29, 2016
Medical Communications, Sales and Marketing FDA, MSD, Zepatier, hepatitis C

The competitive hepatitis C market is to get another contender, with FDA approving MSD’s new combo treatment Zepatier (elbasvir and …

News
clinical trial patient

FDA plans greater diversity in clinical trials

January 29, 2016
Medical Communications, Research and Development FDA, Robert Califf, clinical trial, patient recruitment

The FDA is to focus on increasing patient diversity in clinical trials in 2016, to “ensure that research participants are …

News
The Gateway to Local Adoption Series

Latest content

Japanese pharma outsources earlier as peptide development challenges grow

April 29, 2026

Study suggests phospholipid therapy may impact fatty liver disease outcomes

April 29, 2026

FDA signals support for development of psychedelic therapies in mental healthmental health

April 28, 2026

New web series explores path from ophthalmic research to patient access

April 28, 2026

EMA backs plozasiran for rare lipid disorder with high pancreatitis risk

April 27, 2026